Antibiotic Non-Inferiority Trials To Be Addressed By FDA Advisory Committee

Antibiotic drug sponsors may get more clarity on FDA's policy for non-inferiority margins following the conclusion of a three-day Anti-Infective Drugs Advisory Committee meeting in November